Your browser doesn't support javascript.
loading
One-year follow-up study after patients with severe COVID-19 received human umbilical cord mesenchymal stem cells treatment.
Shi, Lei; Zheng, You; Cheng, Zhi; Ji, Ningfei; Niu, Changming; Wang, Yan; Huang, Tingrong; Li, Ruyou; Huang, Mao; Chen, Xiaolin; Shu, Lei; Wu, Mingjing; Deng, Kaili; Wei, Jing; Wang, Xueli; Cao, Yang; Yan, Jiaxin; Feng, Ganzhu.
Afiliación
  • Shi L; Department of Pulmonary and Critical Medicine, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, 210011, Jiangsu, China.
  • Zheng Y; Department of Respiratory Medicine, Sir Run Run Hospital, Nanjing Medical University, Nanjing, 211166, Jiangsu, China.
  • Cheng Z; Department of Nephrology, Huangshi Hospital of Traditional Chinese Medicine, Huangshi, 435000, Hubei, China.
  • Ji N; Department of Critical Care Medicine, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, 210011, Jiangsu, China.
  • Niu C; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
  • Wang Y; Department of Critical Care Medicine, the Second Affiliated Hospital of Nanjing Medical University, Nanjing, 210011, Jiangsu, China.
  • Huang T; Jiangsu Cell Tech Medical Research Institute, Nanjing, 211166, Jiangsu, China.
  • Li R; Department of Nephrology, Huangshi Hospital of Traditional Chinese Medicine, Huangshi, 435000, Hubei, China.
  • Huang M; Department of Respiratory Medicine, Huangshi Central Hospital, Huangshi, 435000, Hubei, China.
  • Chen X; Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
  • Shu L; Department of Respiratory Medicine, Sir Run Run Hospital, Nanjing Medical University, Nanjing, 211166, Jiangsu, China.
  • Wu M; Department of Respiratory Medicine, Sir Run Run Hospital, Nanjing Medical University, Nanjing, 211166, Jiangsu, China.
  • Deng K; Department of Respiratory Medicine, Sir Run Run Hospital, Nanjing Medical University, Nanjing, 211166, Jiangsu, China.
  • Wei J; Department of Respiratory Medicine, Sir Run Run Hospital, Nanjing Medical University, Nanjing, 211166, Jiangsu, China.
  • Wang X; Department of Respiratory Medicine, Sir Run Run Hospital, Nanjing Medical University, Nanjing, 211166, Jiangsu, China.
  • Cao Y; Department of Respiratory Medicine, Sir Run Run Hospital, Nanjing Medical University, Nanjing, 211166, Jiangsu, China.
  • Yan J; Department of Respiratory Medicine, Sir Run Run Hospital, Nanjing Medical University, Nanjing, 211166, Jiangsu, China.
  • Feng G; Department of Respiratory Medicine, Sir Run Run Hospital, Nanjing Medical University, Nanjing, 211166, Jiangsu, China.
Stem Cell Res Ther ; 13(1): 321, 2022 07 16.
Article en En | MEDLINE | ID: mdl-35842684
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Mesenquimatosas / Células Madre Mesenquimatosas / COVID-19 Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Stem Cell Res Ther Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Células Madre Mesenquimatosas / Células Madre Mesenquimatosas / COVID-19 Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Stem Cell Res Ther Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido